The Memphis Grizzlies are in the midst of the final stretch of the season and gearing up for the playoffs, but they will have ...

A recent update on the Atlanta Braves All-Star starting pitcher provided a potential timetable for his rehab assignment ...

"The government should step in to facilitate lower prices, as has occurred in the rest of the world," writes one reader.

Unique siRNA platform, developed with Nobel Prize Laureate Craig Mello, offers potential for treating multiple dermatology indications ALY-101 is formulated as an intradermal injectable for ...

Brighton Music Hall opened its doors to rising musical royalty, Spencer Sutherland, for the second time, backed by openers ...

The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in ...

For the Utah Jazz, they announced the Jordan Clarkson will be out tonight with Plantar Fasciitis. It looks like the Jazz will ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down ...

The Utah Jazz are back to the grind on Tuesday night, facing off against the Memphis Grizzlies for their fifth of a six-game home stint.

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined ...

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.